PubRank

O Dubourg

Author PubWeight™ 96.64‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A second locus for Marfan syndrome maps to chromosome 3p24.2-p25. Nat Genet 1994 2.71
2 Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res 1997 2.25
3 Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J 1998 2.20
4 Subxiphoid pericardiocentesis guided by contrast two-dimensional echocardiography in cardiac tamponade: experience of 110 consecutive patients. Eur J Echocardiogr 2000 2.13
5 Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 1998 2.04
6 Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients. Radiology 2000 1.81
7 Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur Heart J 1998 1.79
8 Autosomal dominant Marfan-like connective-tissue disorder with aortic dilation and skeletal anomalies not linked to the fibrillin genes. Am J Hum Genet 1993 1.74
9 Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 1997 1.72
10 New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography. AJR Am J Roentgenol 2001 1.66
11 Invasive monitoring combined with two-dimensional echocardiographic study in septic shock. Intensive Care Med 1994 1.51
12 Linkage analysis of five fibrillar collagen loci in a large French Marfan syndrome family. J Med Genet 1990 1.45
13 [Negative D-dimers and peripheral pulmonary embolism]. Arch Mal Coeur Vaiss 2003 1.42
14 Dynamic cardiomyoplasty: effect of discontinuing latissimus dorsi muscle stimulation on left ventricular systolic and diastolic performance and exercise capacity. J Am Coll Cardiol 1995 1.39
15 Left ventricular volume analysis for the detection of coronary artery disease during dobutamine stress echocardiography in patients undergoing vascular surgery. Eur J Echocardiogr 2000 1.38
16 Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology 1999 1.38
17 Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum Mol Genet 2001 1.37
18 Echocardiographic pattern of acute cor pulmonale. Chest 1997 1.33
19 Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations. Neurology 2006 1.30
20 Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J Mol Med (Berl) 1998 1.27
21 Central pulse pressure is a major determinant of ascending aorta dilation in Marfan syndrome. Circulation 1999 1.25
22 Stem cell transplantation in a patient with late-onset nemaline myopathy and gammopathy. Neurology 2008 1.20
23 Coincidence of two genetic forms of Charcot-Marie-Tooth disease in a single family. Neurology 2004 1.20
24 Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 1996 1.18
25 Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1. Neurology 2007 1.13
26 Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 2001 1.13
27 Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the beta-myosin heavy chain gene. J Clin Invest 1993 1.13
28 Peripheral neuropathy and inborn errors of metabolism in adults. J Inherit Metab Dis 2007 1.11
29 Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 1997 1.10
30 Contrast echocardiographic visualization of cough-induced right to left shunt through a patent foramen ovale. J Am Coll Cardiol 1984 1.08
31 Cyclic changes in right ventricular output impedance during mechanical ventilation. J Appl Physiol (1985) 1999 1.08
32 Aneurysms of sinus of Valsalva: two-dimensional echocardiographic diagnosis and recognition of rupture into the right heart cavities. J Am Coll Cardiol 1984 1.06
33 Quantitative two-dimensional echocardiography in massive pulmonary embolism: emphasis on ventricular interdependence and leftward septal displacement. J Am Coll Cardiol 1987 1.05
34 The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol 1997 1.05
35 Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene. Neuromuscul Disord 2008 1.02
36 Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience. J Med Genet 2002 1.01
37 Two-dimensional echocardiographic evaluation of right ventricular size and contractility in acute respiratory failure. Crit Care Med 1985 0.99
38 Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy. J Med Genet 1999 0.95
39 The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2. Am J Hum Genet 1995 0.94
40 Left main coronary artery compression during primary pulmonary hypertension. Chest 1997 0.93
41 Right ventricular volumes by thermodilution in the adult respiratory distress syndrome. A comparative study using two-dimensional echocardiography as a reference method. Chest 1985 0.93
42 Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy. Heart 2002 0.92
43 Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene. Neuromuscul Disord 2003 0.91
44 Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy. Eur Heart J 1998 0.91
45 Penetrance of familial hypertrophic cardiomyopathy. Genet Couns 1997 0.91
46 Charcot-Marie-Tooth features and maculopathy in a patient with Danon disease. Neurology 2004 0.90
47 Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group. Eur Heart J 1999 0.90
48 Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J Hypertens 2000 0.90
49 [Leiomyosarcoma of the superior vena cava: diagnosis by endovascular biopsy]. J Radiol 2000 0.89
50 [Nemaline rod myopathy revealed by acute respiratory failure after an outpatient cataract surgery]. Ann Fr Anesth Reanim 2012 0.88
51 [Isolated and asymptomatic Brugada syndrome. A case report]. Ann Cardiol Angeiol (Paris) 2002 0.88
52 [Aortic insufficiency in Takayasu's disease. Apropos of 3 surgically treated cases and review of the literature]. Arch Mal Coeur Vaiss 1984 0.87
53 Volumetric quantification of coronary artery calcifications using dual-slice spiral CT scanner: improved reproducibility of measurements with 180 degrees linear interpolation algorithm. J Comput Assist Tomogr 2001 0.87
54 The gene for Machado-Joseph disease maps to the same 3-cM interval as the spinal cerebellar ataxia 3 gene on chromosome 14q. Neurobiol Dis 1994 0.86
55 Retrograde catheterization of left ventricle through mechanical aortic prostheses. Eur Heart J 1987 0.86
56 Transesophageal echocardiography for the diagnosis of pulmonary embolism with acute cor pulmonale: a comparison with radiological procedures. Intensive Care Med 1998 0.86
57 [The value of transesophageal echocardiography for the diagnosis of pulmonary embolism with acute pulmonary heart disease]. Arch Mal Coeur Vaiss 1998 0.86
58 Genotype-phenotype analysis in four families with mutations in beta-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy. Hum Mutat 1998 0.85
59 Homozygotes for a R869G mutation in the beta -myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000 0.85
60 [Management of muscle and nerve biopsies: expert guidelines from two French professional societies, Société française de myologie et de l'Association française contre les myopathies]. Rev Neurol (Paris) 2010 0.84
61 Regional specificity of peak hyperemic response in patients with congestive heart failure: correlation with peak aerobic capacity. J Am Coll Cardiol 1993 0.84
62 Familial dilated cardiomyopathy: clinical features in French families. Eur J Heart Fail 1999 0.84
63 Relation between transpulmonary pressure and right ventricular isovolumetric pressure change during respiratory support. Cathet Cardiovasc Diagn 1989 0.84
64 Effects of full-dose heparin anticoagulation on the development of left ventricular thrombosis in acute transmural myocardial infarction. J Am Coll Cardiol 1986 0.83
65 Autonomic and respiratory dysfunction in Charcot-Marie-Tooth disease due to Thr124Met mutation in the myelin protein zero gene. Clin Neurophysiol 2003 0.83
66 [Cardiomyopathy in the peripartum period: current aspects. A multicenter study. 11 cases]. Arch Mal Coeur Vaiss 1990 0.82
67 Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population. Int J Cardiol 2003 0.82
68 [New classifications and pathophysiology of the inflammatory myopathies]. Rev Med Interne 2007 0.81
69 [Helical computed tomography of the aorta and its branches]. J Radiol 1999 0.81
70 Treatment of hemoptysis in Behçet syndrome with pulmonary and bronchial embolization. J Vasc Interv Radiol 1998 0.81
71 [Distal myopathy due to mutations of GNE gene: clinical spectrum and diagnosis]. Rev Neurol (Paris) 2008 0.81
72 Acute myocardial infarction in a patient with severe aortic stenosis and normal coronary arteries. Eur Heart J 1994 0.81
73 Oral enoximone as a substitute for intravenous catecholamine support in end-stage congestive heart failure. Eur Heart J 1994 0.80
74 Adult T-cell leukemia/lymphoma revealed by a surgically cured cardiac valve lymphomatous involvement in an Iranian woman: clinical, immunopathological and viromolecular studies. Leukemia 1993 0.80
75 Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension. J Hypertens 1998 0.79
76 [Quantitative two-dimensional echocardiography in acute pulmonary embolism]. Presse Med 1991 0.79
77 First description of germline mosaicism in familial hypertrophic cardiomyopathy. J Med Genet 2000 0.79
78 [Evaluation of echo-guided pericardiocentesis in cardiac tamponade]. Arch Mal Coeur Vaiss 1998 0.79
79 [Double-blind clinical and echocardiographic study of oral enoximone versus placebo in severe cardiac insufficiency]. Arch Mal Coeur Vaiss 1992 0.79
80 Clinical significance of tolerant strains of streptococci in adults with infective endocarditis. Clin Microbiol Infect 2003 0.78
81 [Intramuscular vascular malformations as a differential diagnosis of focal myositis]. Rev Med Interne 2005 0.78
82 Incidence of tricuspid regurgitation and vena caval backward flow in mechanically ventilated patients. A color Doppler and contrast echocardiographic study. Chest 1995 0.78
83 Efficacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design. J Hum Hypertens 2002 0.77
84 Inspiratory impairment in right ventricular performance during acute asthma. Chest 1987 0.77
85 [Charcot-Marie-Tooth disease: from phenotype to genotype]. Rev Neurol (Paris) 2004 0.77
86 [Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): Clinical, electrophysiological and genetic analysis of 24 patients]. Rev Neurol (Paris) 2013 0.77
87 [Takayasu's disease. Value of digital intravenous angiography. 44 cases]. Presse Med 1986 0.77
88 [Skeletal muscle efficiency in heart failure]. Ann Cardiol Angeiol (Paris) 2004 0.76
89 Identification of a mutation near a functional site of the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. J Mol Cell Cardiol 1994 0.76
90 The SOX10 transcription factor: evaluation as a candidate gene for central and peripheral hereditary myelin disorders. J Neurol 2001 0.76
91 Comparison of irbesartan vs felodipine in the regression after 1 year of left ventricular hypertrophy in hypertensive patients (the SILVER trial). Study of Irbesartan in Left VEntricular hypertrophy Regression. J Hum Hypertens 1998 0.76
92 Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation. Am J Cardiol 1997 0.76
93 Anomalous origin of the left coronary artery arising from the pulmonary trunk: report of an adult case with long-term follow-up after surgery. Eur Radiol 1999 0.75
94 Exclusion of genes coding for proteins of the cytoskeleton and the extracellular matrix in familial hypertrophic cardiomyopathy using a candidate gene approach. C R Acad Sci III 1993 0.75
95 [Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI]. Ann Biol Clin (Paris) 2005 0.75
96 [Contribution of doppler echocardiography in the evaluation of ventricular filling in cardiac insufficiency and estimation of filling pressures]. Arch Mal Coeur Vaiss 1998 0.75
97 [Superior vena cava endoprostheses]. Rev Mal Respir 1999 0.75
98 [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population]. Arch Mal Coeur Vaiss 2006 0.75
99 The need for European Registries in inherited cardiomyopathies. Eur Heart J 2002 0.75
100 [Hereditary neuropathy with liability to pressure palsies]. Rev Neurol (Paris) 2000 0.75
101 [Evaluation of a specific French scale of activity in chronic heart failure. A national multicenter study. Group for Cardiac Insufficiency and Cardiomyopathy of the French Society of Cardiology]. Arch Mal Coeur Vaiss 1999 0.75
102 Patent foramen ovale and sitting position. Anesthesiology 1984 0.75
103 [Long-term outcome of a patient with hypertrophic obstructive cardiomyopathy treated by alcohol septal transcoronary ablation]. Arch Mal Coeur Vaiss 2002 0.75
104 [Cardiac manifestations of Takayasu's disease (excluding hypertensive heart disease) (author's transl)]. J Mal Vasc 1982 0.75
105 [Patency of the foramen ovale in paradoxical embolism. Detection by contrast echocardiography and the cough provocation test]. Presse Med 1983 0.75
106 [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo]. Arch Mal Coeur Vaiss 1983 0.75
107 [Echographic calculation of left ventricular mass in TM mode]. Arch Mal Coeur Vaiss 2004 0.75
108 [The CAPITOL study (Captopril Post Infarction Tolerance). A trial of progressive titration of captopril after myocardial infarct with left ventricular dysfunction]. Arch Mal Coeur Vaiss 1999 0.75
109 [Rapid development of mitral and aortic stenoses with chronic hemodialysis. A report of 2 cases]. Nephrologie 1990 0.75
110 [Paradoxical embolism through a patent foramen ovale. 4 cases]. Presse Med 1983 0.75
111 Controlled, eight-hour haemodynamic study of a sustained-release formulation of isosorbide dinitrate in moderate left ventricular failure. Eur J Clin Pharmacol 1984 0.75
112 [Takayasu's aortitis. Exploration of the aorta and its branches by digital angiography and cross-sectional echography]. Presse Med 1985 0.75
113 [Reflexion of French experts on the key points of the symposium]. Presse Med 2002 0.75
114 [Wide-angle two-dimensional echocardiographic study of the thoracic aorta and its branches]. Arch Mal Coeur Vaiss 1982 0.75
115 [Diagnostic value of a two-dimensional echocardiographic score for left ventricular hypertrophy validated by the Imatron CT scan in familial hypertrophic cardiomyopathy]. Arch Mal Coeur Vaiss 2006 0.75
116 [Incidence of acute cor pulmonale and deep venous thrombosis in acute pulmonary embolism]. Presse Med 2002 0.75
117 [Bidimensional echography in the diagnosis of acute myocardial infarction and its complications in the coronary unit]. Union Med Can 1983 0.75
118 [A new technique of pulmonary arterial angioscopy: capnoangioscopy. An experimental study]. Presse Med 1990 0.75
119 [Demonstration of a fifth locus implicated in familial hypertrophic cardiomyopathies]. Arch Mal Coeur Vaiss 1994 0.75
120 [Diagnosis of atrial septal defects by contrast echocardiography with sensitivity increased by coughing]. Arch Mal Coeur Vaiss 1986 0.75
121 [Yersinia pseudotuberculosis acute pericarditis]. Presse Med 1983 0.75
122 [The role of spiral computerized tomography in the diagnosis of pulmonary embolism]. Arch Mal Coeur Vaiss 2006 0.75
123 [Human pharmacokinetic study of a sustained-release preparation of hydroquinidine: single and chronic administration]. Therapie 1984 0.75
124 Diagnosis of saphenous coronary graft aneurysm by spiral computed tomography. Cardiovasc Intervent Radiol 2000 0.75
125 [Bronchial and pulmonary vaso-occlusions]. Rev Mal Respir 1999 0.75
126 [Contribution of doppler imaging of the myocardium to the study of cardiomyopathies]. Arch Mal Coeur Vaiss 1998 0.75
127 [Semi-automatic measurement of the left ventricular mass from tomodensitometric traces of the left ventricle]. Arch Mal Coeur Vaiss 1999 0.75
128 [Tamponade in patients with systolic left ventricular dysfunction. An atypical presentation]. Presse Med 1998 0.75
129 Circulatory failure in acute pulmonary embolism. Intensive Care Med 1984 0.75
130 [Two-dimensional echocardiography in a cardiac intensive care unit]. Arch Mal Coeur Vaiss 1986 0.75
131 Inotropic agents in the treatment of cardiogenic shock. Pharmacol Ther 1983 0.75
132 [Isolated stenosis of the anterior interventricular artery. Comparison of the effects of medical and surgical treatment (in a randomised series)]. Arch Mal Coeur Vaiss 1985 0.75
133 [Two-dimensional contrast echocardiography during the drainage of hemopericardium with tamponade]. Presse Med 1983 0.75
134 Intravenous digital subtraction angiography in Takayasu's disease. A report of 32 cases. Eur J Radiol 1986 0.75
135 [Physiopathology of mitral mechanics in hypertrophic cardiomyopathy. Groupe de travail "Cardiomyopathies et insuffisance cardiaque" de la Société Française de Cardiologie]. Arch Mal Coeur Vaiss 1994 0.75
136 [Apical left ventricular aneurysm without atrio-ventricular block due to a lamin A/C gene mutation]. Arch Mal Coeur Vaiss 2005 0.75
137 [Coronary involvement in Takayasu's disease. Apropos of 3 cases, of which 2 were surgically treated, and review of the literature]. Arch Mal Coeur Vaiss 1984 0.75
138 [Acute lithium intoxication. Apropos of a case]. Arch Mal Coeur Vaiss 2004 0.75
139 [Prehospital use of haemostatic dressing QuikClot ACS+™ for hemorrhage control of a perineal trauma]. Ann Fr Anesth Reanim 2012 0.75
140 [Unexplained intracardiac thrombus responsible for multiple embolism]. Presse Med 1983 0.75
141 [Right ventricular fibroma. Value of different methods of invasive and noninvasive exploration]. Arch Mal Coeur Vaiss 1984 0.75
142 Variability and reproducibility of quantitative left ventricular angiography. Cathet Cardiovasc Diagn 1989 0.75
143 [Planned predonation with a view to autologous transfusion during cardiac surgery. Preliminary results in 21 patients]. Rev Fr Transfus Hemobiol 1989 0.75
144 [Digitized intravenous angiography in Takayasu's disease. Apropos of 44 cases]. Arch Mal Coeur Vaiss 1986 0.75
145 [Correlations between plasma concentrations of atrial natriuretic factor and right ventricular function in patients with severe cardiac failure]. Arch Mal Coeur Vaiss 1992 0.75
146 [Left-right shunt caused by anomalous implantation of the left coronary artery in the trunk of pulmonary artery. Detection by contrast echocardiography]. Arch Mal Coeur Vaiss 1985 0.75
147 [Primary cardiac tumors]. Presse Med 1987 0.75
148 [Serum sickness after fibrinolysis using intravenous streptokinase in myocardial infarction]. Arch Mal Coeur Vaiss 1988 0.75
149 [Positional occlusion of the descending scapular artery in transverse thoraco-brachial syndrome with neurologic symptoms]. J Radiol 1999 0.75
150 [Update on the study of true and false left ventricular aneurysms by 2-dimensional echocardiography]. Arch Mal Coeur Vaiss 1982 0.75
151 [Coronary steal syndrome by systemic pulmonary hypervascularization fed by a mammary-left anterior descending artery bypass. Treatment by embolization]. J Radiol 2001 0.75
152 [Anti-angina effect of amiodarone versus delayed-action propranolol. A double-blind randomized study]. Arch Mal Coeur Vaiss 1990 0.75